Dr. Jeffrey Cirillo is leading a national team that hopes to repurpose an existing tuberculosis vaccine to fight the coronavirus. About 700 participants are needed in Texas for the clinical trial.
While the pandemic and oil glut create a double dose of devastation, three Texas A&M scholars tell Chancellor John Sharp that they see new economic opportunities rising from the rubble.
Scientists are recruiting hundreds of medical workers to test the existing vaccine's ability to mitigate the effects of the illness. Results are expected within six months.
By Keith Randall, Texas A&M University Division of Marketing & Communications Calling the new facility a “game-changer,” Texas A&M University officials dedicated the Galveston campus’ new Aggie Special Events Center (ASEC) Friday and said it is a landmark event for the school. The new facility completes Phase…
